51. The $800 Million Pill: the Truth Behind the Cost of New Drugs
by Goozner, Merrill 
Price: USD 4.00
Dealer: Alibris, Half Price Books Inc via Alibris
Description: University of California Press 2004 hardcover Very good Connecting readers with great books since 1972! Used books may not include companion materials, and may have some shelf wear or limited writing. We ship orders daily and Customer Service is our top priority! 

52. The $800 Million Pill: the Truth Behind the Cost of New Drugs
by Goozner, Merrill 
Price: USD 6.39
Dealer: Alibris, Half Price Books Inc via Alibris
Description: University of California Press 2004 hardcover Very good Connecting readers with great books since 1972! Used books may not include companion materials, and may have some shelf wear or limited writing. We ship orders daily and Customer Service is our top priority! 

53. The $800 Million Pill: the Truth Behind the Cost of New Drugs
by Goozner, Merrill 
Price: USD 1.41
Dealer: Alibris, Jenson Books Inc via Alibris
Description: University of California Press 2004 Hard cover This item shows signs of wear from consistent use, but it remains in good condition and works perfectly. All pages and cover are intact, but may have aesthetic issues such as small tears, bends, scratches, and scuffs. Spine may also show signs of wear. Pages may include some notes and highlighting. May include "From the library of" labels. Satisfaction Guaranteed. 

54. The $800 Million Pill: the Truth Behind the Cost of New Drugs
by Goozner, Merrill 
Price: USD 1.49
Dealer: Alibris, Poquette's Books via Alibris
Description: University of California Press 2004 hardcover Good 

55. The $800 Million Pill: the Truth Behind the Cost of New Drugs
by Goozner, Merrill 
Price: USD 2.77
Dealer: Alibris, ThriftBooks-Atlanta via Alibris
Description: University of California Press 2004 Hardcover Fine Pages are clean and are not marred by notes or folds of any kind. ~ ThriftBooks: Read More, Spend Less. 

56. The $800 Million Pill: the Truth Behind the Cost of New Drugs
by Goozner, Merrill 
Price: USD 2.77
Dealer: Alibris, ThriftBooks-Atlanta via Alibris
Description: University of California Press 2004 Hardcover Very good May have limited writing in cover pages. Pages are unmarked. ~ ThriftBooks: Read More, Spend Less. 

57. The $800 Million Pill: the Truth Behind the Cost of New Drugs
by Goozner, Merrill 
Price: USD 2.77
Dealer: Alibris, ThriftBooks-Dallas via Alibris
Description: University of California Press 2004 Hardcover Very good May have limited writing in cover pages. Pages are unmarked. ~ ThriftBooks: Read More, Spend Less. 

58. The $800 Million Pill: the Truth Behind the Cost of New Drugs
by Goozner, Merrill 
Price: USD 4.95
Dealer: Alibris, Wonder Book - Member ABAA/ILAB via Alibris
Description: University of California Press 2004 Hard cover Very Good Very Good condition. Very Good dust jacket. A copy that may have a few cosmetic defects. May also contain light spine creasing or a few markings such as an owner's name, short gifter's inscription or light stamp. Bundled media such as CDs, DVDs, floppy disks or access codes may not be included. 

59. The $800 Million Pill: the Truth Behind the Cost of New Drugs
by Goozner, Merrill 
Price: USD 20.59
Dealer: Alibris, h&hbooks24 via Alibris
Description: University of California Press 2004 hardcover Good Size: 6x1x9; 

60. The $800 Million Pill: the Truth Behind the Cost of New Drugs
by Merrill Goozner 
Price: USD 10.00
Dealer: Alibris, Montclair Book Center via Alibris
Description: University of California Press 2004 Hardcover USED Good 

61. The $800 Million Pill: the Truth Behind the Cost of New Drugs
by Merrill Goozner 
Price: USD 2.48
Dealer: Alibris, ThriftBooks-Reno via Alibris
Description: University of California Press 2004 Hardcover Very good May have limited writing in cover pages. Pages are unmarked. ~ ThriftBooks: Read More, Spend Less. 

62. THE $800 MILLION PILL: THE TRUTH
by Goozner, Merrill 
Price: USD 58.81
Dealer: Abebooks, BennettBooksLtd
Description: ISBN10: 0520239458, ISBN13: 9780520239456, [publisher: University of California Press] Hardcover New. In shrink wrap. Looks like an interesting title! 1.15 [LOS ANGELES, CA, U.S.A.] [Publication Year: 2004]  

63. The $800 Million Pill; The Truth Behind the Cost of New Drugs
by Goozner Merrill 
Price: USD 75.00
Dealer: Biblio, Ground Zero Books
Description: Berkeley: University of California Press, Date: 2004. First Printing [Stated]. Hardcover. Very Good/Very Good. [6], 297, [1] pages. Minor ding to several pages top edge. DJ has minor wear. Includes Introduction, Notes, Bibliography, Acknowledgments, and Index, as well as chapters on Biohype; Directed Research; and Big Pharma. Inscribed by the author on the title page. Inscription reads: Dave, For when you did into this policy arena. Best wishes, Merrill Goozner. Merrill Goozner, is an American journalist, author and educator. He served as editor of Modern Healthcare and ModernHealthcare, a weekly news magazine and daily news website covering the healthcare industry, from December 2012 to April 2017. Since then, he writes a weekly column for the magazine as well as writes and edits GoozNews, an online newsletter. His prior career included five years as a printer with the Cincinnati Post; five years as Cincinnati director of the Ohio Public Interest Campaign (and writer/editor of the Cincinnati AFL-CIO Chronicle); a year as reporter for the Hammond (Ind.) Times; four years with Crain's Chicago Business; 13 years with the Chicago Tribune, including four years as Tokyo bureau chief and Chief Asia Correspondent (1991-95) and two years as Chief Economics Correspondent (1998-2000). He subsequently became a professor of business journalism at New York University (2000-2003) and director of the Integrity in Science Project at the Center for Science in the Public Interest (2004-2009). The $800 Million Pill suggests ways that the government's role in testing new medicines could be expanded to eliminate the private-sector waste driving up the cost of existing drugs. Pharmaceutical firms should be compelled to refocus their human and financial resources on true medical innovation, Goozner insists. This book is essential reading for everyone concerned about the politically charged topics of drug pricing, Medicare coverage, national health care, and the role of pharmaceutical companies in developing countries. Why do lifesaving prescription drugs cost so much? Drug companies insist that prices reflect the millions they invest in research and development. In this gripping exposé, Merrill Goozner contends that American taxpayers are in fact footing the bill twice: once by supporting government-funded research and again by paying astronomically high prices for prescription drugs. Goozner demonstrates that almost all the important new drugs of the past quarter-century actually originated from research at taxpayer-funded universities and at the National Institutes of Health. He reports that once the innovative work is over, the pharmaceutical industry often steps in to reap the profit. Goozner shows how drug innovation is driven by dedicated scientists intent on finding cures for diseases, not by pharmaceutical firms whose bottom line often takes precedence over the advance of medicine. A university biochemist who spent twenty years searching for a single blood protein that later became the best-selling biotech drug in the world, a government employee who discovered the causes for dozens of crippling genetic disorders, and the Department of Energy-funded research that made the Human Genome Project possible--these engrossing accounts illustrate how medical breakthroughs actually take place. 2004. University of California Press ISBN 0520239458 9780520239456 [US] 

64. The $800 Million Pill; The Truth Behind the Cost of New Drugs
by Goozner, Merrill 
Price: USD 75.00
Dealer: Abebooks, Ground Zero Books, Ltd.
Description: ISBN10: 0520239458, ISBN13: 9780520239456, [publisher: University of California Press, Berkeley] Hardcover First Edition [6], 297, [1] pages. Minor ding to several pages top edge. DJ has minor wear. Includes Introduction, Notes, Bibliography, Acknowledgments, and Index, as well as chapters on Biohype; Directed Research; and Big Pharma. Inscribed by the author on the title page. Inscription reads: Dave, For when you did into this policy arena. Best wishes, Merrill Goozner. Merrill Goozner, is an American journalist, author and educator. He served as editor of Modern Healthcare and ModernHealthcare, a weekly news magazine and daily news website covering the healthcare industry, from December 2012 to April 2017. Since then, he writes a weekly column for the magazine as well as writes and edits GoozNews, an online newsletter. His prior career included five years as a printer with the Cincinnati Post; five years as Cincinnati director of the Ohio Public Interest Campaign (and writer/editor of the Cincinnati AFL-CIO Chronicle); a year as reporter for the Hammond (Ind.) Times; four years with Crain's Chicago Business; 13 years with the Chicago Tribune, including four years as Tokyo bureau chief and Chief Asia Correspondent (1991-95) and two years as Chief Economics Correspondent (1998-2000). He subsequently became a professor of business journalism at New York University (2000-2003) and director of the Integrity in Science Project at the Center for Science in the Public Interest (2004-2009). The $800 Million Pill suggests ways that the government's role in testing new medicines could be expanded to eliminate the private-sector waste driving up the cost of existing drugs. Pharmaceutical firms should be compelled to refocus their human and financial resources on true medical innovation, Goozner insists. This book is essential reading for everyone concerned about the politically charged topics of drug pricing, Medicare coverage, national health care, and the role of pharmaceutical companies in developing countries. Why do lifesaving prescription drugs cost so much? Drug companies insist that prices reflect the millions they invest in research and development. In this gripping exposé, Merrill Goozner contends that American taxpayers are in fact footing the bill twice: once by supporting government-funded research and again by paying astronomically high prices for prescription drugs. Goozner demonstrates that almost all the important new drugs of the past quarter-century actually originated from research at taxpayer-funded universities and at the National Institutes of Health. He reports that once the innovative work is over, the pharmaceutical industry often steps in to reap the profit. Goozner shows how drug innovation is driven by dedicated scientists intent on finding cures for diseases, not by pharmaceutical firms whose bottom line often takes precedence over the advance of medicine. A university biochemist who spent twenty years searching for a single blood protein that later became the best-selling biotech drug in the world, a government employee who discovered the causes for dozens of crippling genetic disorders, and the Department of Energy-funded research that made the Human Genome Project possible--these engrossing accounts illustrate how medical breakthroughs actually take place. [Silver Spring, MD, U.S.A.] [Publication Year: 2004]  

65. The $800 Million Pill; the Truth Behind the Cost of New Drugs
by Goozner, Merrill 
Price: USD 75.00
Dealer: Alibris, Ground Zero Books, Ltd. via Alibris
Description: Berkeley University of California Press 2004 First Printing [Stated] Hardcover Very Good in Very Good jacket [6], 297, [1] pages. Minor ding to several pages top edge. DJ has minor wear. Includes Introduction, Notes, Bibliography, Acknowledgments, and Index, as well as chapters on Biohype; Directed Research; and Big Pharma. Inscribed by the author on the title page. Inscription reads: Dave, For when you did into this policy arena. Best wishes, Merrill Goozner. Merrill Goozner, is an American journalist, author and educator. He served as editor of Modern Healthcare and ModernHealthcare, a weekly news magazine and daily news website covering the healthcare industry, from December 2012 to April 2017. Since then, he writes a weekly column for the magazine as well as writes and edits GoozNews, an online newsletter. His prior career included five years as a printer with the Cincinnati Post; five years as Cincinnati director of the Ohio Public Interest Campaign (and writer/editor of the Cincinnati AFL-CIO Chronicle); a year as reporter for the Hammond (Ind. ) Times; four years with Crain's Chicago Business; 13 years with the Chicago Tribune, including four years as Tokyo bureau chief and Chief Asia Correspondent (1991-95) and two years as Chief Economics Correspondent (1998-2000). He subsequently became a professor of business journalism at New York University (2000-2003) and director of the Integrity in Science Project at the Center for Science in the Public Interest (2004-2009). The $800 Million Pill suggests ways that the government's role in testing new medicines could be expanded to eliminate the private-sector waste driving up the cost of existing drugs. Pharmaceutical firms should be compelled to refocus their human and financial resources on true medical innovation, Goozner insists. This book is essential reading for everyone concerned about the politically charged topics of drug pricing, Medicare coverage, national health care, and the role of pharmaceutical companies in developing countries. Why do lifesaving prescription drugs cost so much? Drug companies insist that prices reflect the millions they invest in research and development. In this gripping exposé, Merrill Goozner contends that American taxpayers are in fact footing the bill twice: once by supporting government-funded research and again by paying astronomically high prices for prescription drugs. Goozner demonstrates that almost all the important new drugs of the past quarter-century actually originated from research at taxpayer-funded universities and at the National Institutes of Health. He reports that once the innovative work is over, the pharmaceutical industry often steps in to reap the profit. Goozner shows how drug innovation is driven by dedicated scientists intent on finding cures for diseases, not by pharmaceutical firms whose bottom line often takes precedence over the advance of medicine. A university biochemist who spent twenty years searching for a single blood protein that later became the best-selling biotech drug in the world, a government employee who discovered the causes for dozens of crippling genetic disorders, and the Department of Energy-funded research that made the Human Genome Project possible--these engrossing accounts illustrate how medical breakthroughs actually take place.